Published in Mol Biochem Parasitol on September 05, 2006
Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev (2009) 3.41
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One (2007) 2.66
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother (2008) 1.86
Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe (2013) 1.58
Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Malar J (2009) 1.26
Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region. Antimicrob Agents Chemother (2009) 1.18
Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax. Trends Parasitol (2012) 1.17
Emerging Plasmodium vivax resistance to chloroquine in South America: an overview. Mem Inst Oswaldo Cruz (2014) 1.09
Malaria drug resistance: new observations and developments. Essays Biochem (2011) 1.03
In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother (2012) 1.03
Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon. PLoS One (2014) 0.92
Production of recombinant proteins from protozoan parasites. Trends Parasitol (2010) 0.88
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility. Antimicrob Agents Chemother (2015) 0.84
Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum. PLoS One (2012) 0.82
Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia. Malar J (2015) 0.78
Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat. Malar J (2015) 0.76
Genetic Diversity of Dihydropteroate synthetase Gene (dhps) of Plasmodium vivax in Hormozgan Province, Iran. Iran J Parasitol (2016) 0.75
The chaperonin TRiC forms an oligomeric complex in the malaria parasite cytosol. Cell Microbiol (2017) 0.75
Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms. Sci Rep (2017) 0.75
Plasmodium falciparum and P. vivax demonstrate contrasting chloroquine resistance reversal phenotypes. Antimicrob Agents Chemother (2017) 0.75
Comparison of two methods for transformation of Plasmodium knowlesi: Direct schizont electroporation and spontaneous plasmid uptake from plasmid-loaded red blood cells. Mol Biochem Parasitol (2017) 0.75
Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature (2008) 5.96
The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science (2011) 3.30
Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol (2004) 3.30
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med (2007) 2.94
Plasmodium biology: genomic gleanings. Cell (2003) 2.89
Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe (2008) 2.66
Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol (2002) 2.57
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A (2009) 2.54
Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis (2012) 2.53
Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet (2010) 2.48
Malaria biology and disease pathogenesis: insights for new treatments. Nat Med (2013) 2.38
Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg (2003) 2.29
Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A (2008) 2.19
Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature (2005) 2.17
Plasmodium falciparum var genes are regulated by two regions with separate promoters, one upstream of the coding region and a second within the intron. J Biol Chem (2003) 2.16
Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am J Trop Med Hyg (2005) 2.02
Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg (2012) 1.97
Genetic linkage and association analyses for trait mapping in Plasmodium falciparum. Nat Rev Genet (2007) 1.68
Mechanisms underlying mutually exclusive expression of virulence genes by malaria parasites. EMBO Rep (2007) 1.62
Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp Parasitol (2005) 1.58
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol (2009) 1.52
Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Mol Microbiol (2006) 1.51
A silenced Plasmodium falciparum var promoter can be activated in vivo through spontaneous deletion of a silencing element in the intron. Eukaryot Cell (2005) 1.33
High recombination rates and hotspots in a Plasmodium falciparum genetic cross. Genome Biol (2011) 1.27
A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. Infect Immun (2006) 1.27
Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots. J Cell Sci (2005) 1.24
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. J Infect Dis (2012) 1.23
Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state. Blood (2002) 1.23
Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT. J Biol Chem (2005) 1.22
Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol Biochem Parasitol (2009) 1.20
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep (2012) 1.16
Variant genes and the spleen in Plasmodium vivax malaria. Int J Parasitol (2004) 1.16
Plasmodium vivax and the importance of the subtelomeric multigene vir superfamily. Trends Parasitol (2008) 1.14
PfEMP1 expression is reduced on the surface of knobless Plasmodium falciparum infected erythrocytes. J Cell Sci (2005) 1.13
Paucity of Plasmodium vivax mature schizonts in peripheral blood is associated with their increased cytoadhesive potential. J Infect Dis (2014) 1.13
Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. PLoS One (2011) 1.10
Disruption of a Plasmodium falciparum gene linked to male sexual development causes early arrest in gametocytogenesis. Proc Natl Acad Sci U S A (2005) 1.08
Multi-character population study of the vir subtelomeric multigene superfamily of Plasmodium vivax, a major human malaria parasite. Mol Biochem Parasitol (2006) 1.08
Malaria drug resistance: new observations and developments. Essays Biochem (2011) 1.03
Transporter of a malaria catastrophe. Nat Med (2004) 1.02
Reticulocyte-prone malaria parasites predominantly invade CD71hi immature cells: implications for the development of an in vitro culture for Plasmodium vivax. Malar J (2013) 1.01
Plasmodium vivax malaria in Mali: a study from three different regions. Malar J (2012) 1.01
Hemoglobin C modulates the surface topography of Plasmodium falciparum-infected erythrocytes. J Struct Biol (2005) 0.98
Extense variant gene family repertoire overlap in Western Amazon Plasmodium falciparum isolates. Mol Biochem Parasitol (2006) 0.97
Various PfRH5 polymorphisms can support Plasmodium falciparum invasion into the erythrocytes of owl monkeys and rats. Mol Biochem Parasitol (2013) 0.97
A comparison of anemia in hemoglobin C and normal hemoglobin A children with Plasmodium falciparum malaria. Acta Trop (2004) 0.96
A new computational approach redefines the subtelomeric vir superfamily of Plasmodium vivax. BMC Genomics (2013) 0.96
Spleen rupture in a case of untreated Plasmodium vivax infection. PLoS Negl Trop Dis (2012) 0.93
Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles. PLoS One (2012) 0.91
On cytoadhesion of Plasmodium vivax: raison d'être? Mem Inst Oswaldo Cruz (2011) 0.91
Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya. BMC Med Genet (2014) 0.91
Plasmodium falciparum: new vector with bi-directional promoter activity to stably express transgenes. Exp Parasitol (2003) 0.91
Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil. Malar J (2006) 0.90
Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malar J (2011) 0.90
Coevolutionary genetics of Plasmodium malaria parasites and their human hosts. Integr Comp Biol (2002) 0.87
Modulation of malaria virulence by determinants of Plasmodium falciparum erythrocyte membrane protein-1 display. Curr Opin Hematol (2006) 0.87
High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria. Acta Trop (2011) 0.87
Clinical and molecular aspects of severe malaria. An Acad Bras Cienc (2005) 0.87
Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl Trop Dis (2013) 0.86
A high-throughput method to detect Plasmodium falciparum clones in limiting dilution microplates. Malar J (2012) 0.86
Malaria-protective traits at odds in Africa? Nat Genet (2005) 0.86
Non-opsonising aggregates of IgG and complement in haemoglobin C erythrocytes. Br J Haematol (2006) 0.85
A nonpermeant biotin derivative gains access to the parasitophorous vacuole in Plasmodium falciparum-infected erythrocytes permeabilized with streptolysin O. J Biol Chem (2002) 0.85
PfCG2, a Plasmodium falciparum protein peripherally associated with the parasitophorous vacuolar membrane, is expressed in the period of maximum hemoglobin uptake and digestion by trophozoites. Mol Biochem Parasitol (2005) 0.84
Red blood cells derived from peripheral blood and bone marrow CD34⁺ human haematopoietic stem cells are permissive to Plasmodium parasites infection. Mem Inst Oswaldo Cruz (2013) 0.83
An evaluation of concurrent G6PD (A-) deficiency and sickle cell trait in Malian populations of children with severe or uncomplicated P. falciparum malaria. Am J Hematol (2011) 0.82
Quinine treatment selects the pfnhe-1 ms4760-1 polymorphism in Malian patients with Falciparum malaria. J Infect Dis (2012) 0.80
Expression of non-TLR pattern recognition receptors in the spleen of BALB/c mice infected with Plasmodium yoelii and Plasmodium chabaudi chabaudi AS. Mem Inst Oswaldo Cruz (2012) 0.79
Pilot survey of expressed sequence tags (ESTs) from the asexual blood stages of Plasmodium vivax in human patients. Malar J (2003) 0.77
Tetracysteine-based fluorescent tags to study protein localization and trafficking in Plasmodium falciparum-infected erythrocytes. PLoS One (2011) 0.76
First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium. Am J Trop Med Hyg (2012) 0.75
Transient transfection of Plasmodium vivax blood-stage parasites. Methods Mol Biol (2013) 0.75